QT
CGEM icon

Quantbot Technologies’s Cullinan Oncology CGEM Stock Holding History

Quantbot Technologies’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53K Buy
2,911
+2,789
+2,286% +$41.4K ﹤0.01% 1624
2026
Q1 		$1.73K Buy
+122
New +$1.57K ﹤0.01% 1614
2023
Q1 		– Sell
-400
Closed -$4.22K – 1601
2022
Q4 		$4.22K Sell
400
-800
-67% -$9.72K ﹤0.01% 1565
2022
Q3 		$15K Buy
+1,200
New +$16.2K ﹤0.01% 1386

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Quantbot Technologies's CGEM Position: Q2 2026 in Review

Quantbot Technologies increased its Cullinan Oncology (CGEM) stake by 2,286% in Q2 2026, buying an estimated $41.4K and bringing the position to 2,911 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Quantbot Technologies first reported a position in CGEM in Q3 2022 and has held it in 4 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Quantbot Technologies held 2,911 shares of Cullinan Oncology worth $53K as of Q2 2026.
  • Quantbot Technologies bought 2,789 Cullinan Oncology shares in Q2 2026, an estimated $41.4K.
  • Cullinan Oncology made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1624 holding.
  • Quantbot Technologies first reported a position in Cullinan Oncology in Q3 2022 and has held it in 4 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.